{"brief_title": "Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation", "brief_summary": "This is a phase IIIb comparative study of entecavir 1.0 mg once daily (QD) vs. adefovir 10 mg QD in patients who have chronic hepatitis B infection and hepatic decompensation. The patients are treated for 96 weeks after the last subject is randomized.", "condition": "Hepatitis B", "intervention_type": "Drug", "intervention_name": "Adefovir (ADV)", "description": "Tablets, Oral, 10 mg, once daily, 96 weeks from the time the last patient is randomized", "arm_group_label": "A2", "other_name": "BMS-200475", "criteria": "Inclusion - Child-Pugh (CP) score >= 7 - Hepatitis B virus (HBV) viremia Exclusion - Alanine aminotransferase (ALT) > 15 x upper limit of normal (ULN) - Human immunodeficiency virus (HIV)/hepatitis C virus (HCV)/hepatitis D virus (HDV) coinfection", "gender": "All", "minimum_age": "16 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00065507.xml"}